Logo

American Heart Association

  13
  0


Final ID: MDP260

Feasibility of Deep Sedation for Catheter Ablation of Atrial Fibrillation Using Pulsed Field Ablation

Abstract Body (Do not enter title and authors here): Introduction: General anesthesia is commonly utilized during catheter ablation of atrial fibrillation (AF) in the United States, providing patient immobility and permitting esophageal temperature management for radiofrequency ablation. Pulsed field ablation (PFA) is associated with shorter procedure time, less risk of esophageal injury, and less dependence on catheter stability compared with radiofrequency ablation. There are limited data available on performing the procedure with deep sedation as an alternative to general anesthesia with endotracheal intubation.
Methods: Consecutive patients who underwent catheter ablation of AF at Endeavor Health (Chicago, IL) using pulsed field ablation (Farapulse, Boston Scientific, Marlborough, MA or PulseSelect, Medtronic, Minneapolis, MN) and deep sedation between March and May 2024 were retrospectively included in this study. Deep sedation (monitored anesthesia care) was administered by a certified registered nurse anesthetist and attending anesthesiologist, consisting of bolus and infusion dosing of propofol, dexmedetomidine, fentanyl, and midazolam at the discretion of the practitioner with continuous monitoring of vital signs and end-tidal CO2. The primary endpoint was the rate of airway complications or requirement for conversion to general anesthesia. Secondary endpoints were the rate of acute procedural success (all pulmonary veins isolated), total time in the EP lab, procedure time (from lidocaine to removal of sheaths), and non-procedure time (difference between total time in lab and procedure time).
Results: A total of 40 patients (mean age 70.4 ± 13.6 years, BMI 30.2 ± 7.4, 60% females) were included in the analysis. There were no instances of airway complications or conversion from deep sedation to general anesthesia. There was a 100% rate of acute isolation of pulmonary veins. The average total time in the lab was 156.6 ± 41.5 minutes; consisting of a mean procedure time of 107.1 ± 39.7 minutes and non-procedure time 49.5 ± 10.3 minutes.
Conclusions: In this initial experience at a single center, deep sedation (monitored anesthesia care) for PFA was associated with no instances of airway complications. The findings may not apply to patients with moderate or severe obstructive sleep apnea or other pulmonary diseases. Although patients generally were amnestic to the procedure, larger studies incorporating patient-reported outcomes are needed, as well as data regarding long-term clinical outcomes and cost.
  • Patel, Romil  ( University of Chicago Pritzker school of medicine , Northbrook , Illinois , United States )
  • Sam, Riya  ( Endeavor Health , Skokie , Illinois , United States )
  • Singh, Lavisha  ( Endeavor Health , Skokie , Illinois , United States )
  • Fisher, Westby  ( Endeavor Health , Skokie , Illinois , United States )
  • Metzl, Mark  ( Endeavor Health , Skokie , Illinois , United States )
  • Nazari, Jose  ( Endeavor Health , Skokie , Illinois , United States )
  • Ro, Alex  ( Endeavor Health , Skokie , Illinois , United States )
  • Demo, Hany  ( Endeavor Health , Skokie , Illinois , United States )
  • Wasserlauf, Jeremiah  ( Endeavor Health , Skokie , Illinois , United States )
  • Author Disclosures:
    Romil Patel: DO NOT have relevant financial relationships | Riya Sam: DO NOT have relevant financial relationships | Lavisha Singh: No Answer | Westby Fisher: No Answer | Mark Metzl: DO have relevant financial relationships ; Consultant:Atraverse :Active (exists now) ; Consultant:Medtronic :Active (exists now) ; Consultant:J & J Med tech:Active (exists now) ; Consultant:Haemonetics :Active (exists now) | Jose Nazari: No Answer | Alex Ro: No Answer | Hany Demo: No Answer | Jeremiah Wasserlauf: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Pulsed Field Ablation Part Deux!

Saturday, 11/16/2024 , 09:30AM - 10:55AM

Moderated Digital Poster Session

More abstracts on this topic:
A Novel Anti-Thrombotic and Anti-AF Drug without an Adverse Bleeding Problem

Ricchiuti Nikola, Niebrzydowski Maxwell, Richardson Abigail, Yan Jiajie, Ai Xun

A shared gene regulatory network underlies atrial pathophysiology in atrial fibrillation and heart failure mouse models

Lazarevic Sonja, Park David, Moskowitz Ivan, Perez-cerventes Carlos, Wang Zhezhen, Shen Kaitlyn, Gadek Margaret, Chapski Douglas, Mckinsey Timothy, Vondriska Thomas, Ruthenburg Alexander

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available